Abstract
Atrial fibrillation (AF) can increase thrombosis, especially arterial thrombosis, and some studies show that AF patients have a higher risk of developing pulmonary embolism (PE). The objective of our study is to investigate whether there is a direct causal effect of AF on PE. A two-sample Mendelian randomization (MR) approach was utilized to determine whether there is a causal relationship between AF and PE. European population-based consortia provided statistical data on the associations between Single Nucleotide Polymorphisms (SNPs) and relevant traits. The AF dataset was obtained from genome-wide association studies (GWAS) comprising 60,620 cases and 970,216 controls, while a GWAS of 1846 cases and 461,164 controls identified genetic variations associated with PE. Estimation of the causal effect was mainly performed using the random effects inverse-variance weighted method (IVW). Additionally, other tests such as MR-Egger intercept, MR-PRESSO, Cochran’s Q test, “Leave-one-out,” and funnel plots were conducted to assess the extent of pleiotropy and heterogeneity. Using 70 SNPs, there was no evidence to suggest an association between genetically predicted AF and risk of PE with multiplicative random-effects IVW MR analysis (odds ratio = 1.0003, 95% confidence interval: 0.9998–1.0008, P = 0.20). A null association was also observed in other methods. MR-Egger regression and MR-PRESSO respectively showed no evidence of directional (intercept, − 2.25; P = 0.94) and horizontal(P-value in the global heterogeneity test = 0.99) pleiotropic effect across the genetic variants. No substantial evidence was found to support the causal role of AF in the development of PE.
Graphical abstract
Causal effect of atrial fibrillation on pulmonary embolism: a Mendelian randomization study. AF atrial fibrillation, PE pulmonary embolism, GWAS genome-wide association studies, SNPs single nucleotide polymorphisms, OR odds ratio, CI confidence interval.
Similar content being viewed by others
References
Duffett L, Castellucci LA, Forgie MA (2020) Pulmonary embolism: update on management and controversies. BMJ 370:m2177
Spannagl M, Samama MM, Oger E et al (2017) Venous thromboembolism (VTE) in Europe. Thromb Haemost 98:756–764
Liao S, Woulfe T, Hyder S et al (2014) Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. J Thromb Haemost 12:214–219
Lee CH, Lin LJ, Cheng CL et al (2010) Incidence and cumulative recurrence rates of venous thromboembolism in the taiwanese population. J Thromb Haemost 8:1515–1523
Poli C, Raffin C, Dojcinovic D et al (2013) MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer. Haematologica 98:316–322
Benjamin EJ, Muntner P, Alonso A et al (2019) Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139:e56–e528
Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498
Le Moigne E, Timsit S, Ben Salem D et al (2019) Patent Foramen Ovale and ischemic stroke in patients with pulmonary embolism: a prospective cohort study. Ann Intern Med 170:756–763
Anfinogenova ND, Vasiltseva OY, Vrublevsky AV et al (2020) Right atrial thrombosis and pulmonary embolism: a narrative review. Semin Thromb Hemost 46:895–907
Ishihara Y, Saijo T, Namiki A, Suzuki M, Hirai H, Yamaguchi T (2002) Left atrial thrombus causing pulmonary embolism by passing through an atrial septal defect. Circ J 66:109–110
Enga KF, Rye-Holmboe I, Hald EM et al (2015) Atrial fibrillation and future risk of venous thromboembolism:the Tromso study. J Thromb Haemost 13:10–16
Friberg L, Svennberg E (2020) A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism. Thromb Res 195:238–242
Gex G, Gerstel E, Righini M et al (2012) Is atrial fibrillation associated with pulmonary embolism? J Thromb Haemost 10:347–351
Tin A, Kottgen A (2021) Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer. J Am Soc Nephrol 32:2400–2407
Cresti A, Garcia-Fernandez MA, Miracapillo G et al (2014) Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter. J Am Soc Echocardiogr 27:1200–1207
Verbanck M, Chen CY, Neale B et al (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50:693–698
Kukla P, McIntyre WF, Koracevic G et al (2015) Relation of atrial fibrillation and right-sided cardiac thrombus to outcomes in patients with acute pulmonary embolism. Am J Cardiol 115:825–830
Wang CC, Lin CL, Wang GJ et al (2015) Atrial fibrillation associated with increased risk of venous thromboembolism: a population-based cohort study. Thromb Haemost 113:185–192
Tan Q, Zhang S, Qi X et al (2017) Permanent atrial fibrillation impairs the function of circulating endothelial progenitor cells. Postgrad Med 129:198–204
Watson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fi brillation: Virchow’s triad revisited. Lancet 373:155–166
Krajewska A, Ptaszynska-Kopczynska K, Kiluk I et al (2017) Paroxysmal atrial fibrillation in the course of acute pulmonary embolism: clinical significance and impact on prognosis. Biomed Res Int 2017:5049802
Bashir M, Asher CR, Garcia MJ et al (2001) Right atrial spontaneous echo contrast and thrombi in atrial fibrillation: a transesophageal echocardiography study. J Am Soc Echocardiogr 14:122–127
Subramaniam B, Riley MF, Panzica PJ et al (2006) Transesophageal echocardiographic assessment of right atrial appendage anatomy and function: comparison with the left atrial appendage and implications for local thrombus formation. J Am Soc Echocardiogr 19:429–433
Thomas L, Abhayaratna WP (2017) Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging 10:65–77
Keren G, Sherez J, Zelcer AA, Megidish R, Miller HI, Laniado S (1987) Atrial fibrition and atrial e&r t in patients with mitral stenosis. Am Heart J 1987:1146–1155
Klovaite J, Benn M, Nordestgaard BG (2015) Obesity as a causal risk factor for deep venous thrombosis: a mendelian randomization study. J Intern Med 277:573–584
Chatterjee NA, Giulianini F, Geelhoed B et al (2017) Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization. Circulation 135:741–754
Sharashova E, Wilsgaard T, Ball J et al (2020) Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the tromso study. Eur Heart J 41:1554–1562
Severinsen MT, Kristensen SR, Johnsen SP et al (2009) Anthropometry, body fat, and venous thromboembolism: a danish follow-up study. Circulation 120:1850–1857
Steffen LM, Cushman M, Peacock JM et al (2009) Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost 7:746–751
Ageno W, Becattini C, Brighton T et al (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93–102
Hald EM, Rinde LB, Lochen ML et al (2018) Atrial fibrillation and cause-specific risks of pulmonary embolism and ischemic stroke. J Am Heart Assoc 7:e006502
January CT, Wann LS, Calkins H et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation 140:e125–e151
Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke—the Framingham study. Neurology 28:973–977
Wolf PA, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983–988
Bekwelem W, Connolly SJ, Halperin JL et al (2015) Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes. Circulation 132:796–803
Hess CN, Huang Z, Patel MR et al (2019) Acute limb ischemia in peripheral artery disease. Circulation 140:556–565
Funding
This work was financially supported by National Natural Science Foundation of China (81201788).
Author information
Authors and Affiliations
Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
Ethical approval was not provided for this study on human participants because ethical approval and consent to participate were carried out in the original publications.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
11239_2023_2903_MOESM1_ESM.xlsx
Characteristics of SNPs used as instrumental variables for atrial fibrillation. SNP, single nucleotide polymorphism; SE, standard error; R2 = 2*(1 − eaf)*eaf*(beta)2; F = (R2/1 − R2)(N-2). Supplementary material 1 (XLSX 25.5 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, G., Chen, T., Zhang, X. et al. Causal effect of atrial fibrillation on pulmonary embolism: a mendelian randomization study. J Thromb Thrombolysis 57, 212–219 (2024). https://doi.org/10.1007/s11239-023-02903-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-023-02903-w